<DOC>
	<DOCNO>NCT00790140</DOCNO>
	<brief_summary>This study aim examine whether provide tube feed formula enrich omega-3 fat well traditional standard tube feeding term preserve nutritional status , improve immune function reduce medical complication follow major upper Gut cancer surgery .</brief_summary>
	<brief_title>Trial Enteral Nutrition Enriched With Eicosapentaenoic Acid ( EPA ) Upper Gastrointestinal Cancer Surgery</brief_title>
	<detailed_description>Title A double blind randomize control trial investigate effect enteral nutritional supplement enrich Eicosapentaenoic acid long term nutritional status post operatively specifically maintenance lean body mass , potential impact quality life well examine stress response immune function patient undergoing surgical treatment esophageal cancer . Investigational medicinal Product ( ) : Prosure ( Abbott Laboratories ) Comparator : Ensure Plus ( Abbott Laboratories ) Study Objectives To examine whether prolonged supplementation nutritional supplement enrich Eicosapentaenoic acid superior standard nutritional product term promote anabolism improve quality life patient undergoing surgical treatment esophageal cancer . Study Design - Prospective randomize controlled trial . Primary Endpoints : - Quality life Scores use EORTC Questionnaires - Nutritional status day 21 post oesophagectomy and/or total gastrectomy ( specifically lean body mass ) patient follow Secondary Endpoints : - Effects immuno-inflammatory response surgery - Post operative Clinical outcome include SIRS , sepsis organ failure</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Adult ( male &amp; female ) patient &gt; 18 year resectable esophageal cancer Patients metastatic disease , Nonoperable case , Patients require chemotherapy/radiotherapy early follow surgery , Patients know immunological disorder , Emergency esophagectomy case , Patients cardiac , liver renal failure , Active small intestinal disease eg Crohns disease , Allergy ingredient , Uncontrollable Diabetes , Use medication know affect eicosanoid metabolism two week prior trial , Use fish oil/n3 fatty acid , Drug Abuse , Unable take preparation 5 day preoperatively , Pregnant woman , Cessation enteral feed longer 3 consecutive day post operatively medical/surgical reason ( e.g . Chyle leak ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Esophageal Cancer</keyword>
	<keyword>esophagectomy</keyword>
	<keyword>enteral feeding</keyword>
	<keyword>body composition</keyword>
	<keyword>immunology</keyword>
</DOC>